HCPLive
IDWeek 2013 is "an annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA) and the Pediatric Infectious Diseases Society (PIDS). With the theme 'Advancing Science, Improving Care,' IDWeek features the latest science and bench-to-bedside approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases, including HIV, across the lifespan."
IDWeek 2013

IDWeek 2013 | IDWeek 2013

Conference Coverages

Minimally Absorbed Crofelemer Relieves Noninfectious Diarrhea Symptoms in Patients with HIV
Minimally Absorbed Crofelemer Relieves Noninfectious Diarrhea Symptoms in Patients with HIV
Long-term usage of crofelemer, a drug that relieves noninfectious diarrhea symptoms in patients with HIV, was well-tolerated and produced few adverse events in a recent study.
Physician Access to Fecal Microbial Transplant for Recurrent Clostridium Difficile Infection Is Limited in the US
Although fecal microbial transplant is highly effective in treating recurrent C. difficile infection, a survey of infectious disease specialists shows that several barriers prevent the treatment from being available at most institutions.
Daptomycin Is Highly Effective for Methicillin-resistant Staphylococcus Aureus (MRSA) Infections That Have a High Vancomycin MIC
Study results show that daptomycin cleared MRSA infections within four days of treatment in 80% of patients and was particularly effective against extra-vascular infections.
Proton Pump Inhibitors Increase the Risk of Developing Community-acquired Pneumonia
Acid reduction from PPI treatment may alter bacterial flora in the digestive system, which may increase an individual’s susceptibility to infection.
Eliminating Induction Dose and Shortening Interferon-free Combination Treatment Reduces Viral Load in Patients with Hepatitis C
Shortening IFN-free combination treatment of chronic HCV to 16 weeks and eliminating the induction dose of deleobuvir reduces viral load and treatment-induced side effects, according to a recent clinical trial.
Stribild Is More Effective and Produces Fewer Side Effects than Atripla in African American Patients with HIV
Study results show that patients treated with Stribild had significantly reduced viral load and increased CD4 counts after 96 weeks, with fewer patients discontinuing treatment due to side effects.
Customized Order Entry Sets Reduce Errors in Prescribing HIV Medication
Implementation of computerized customized order entry sets in a large urban hospital reduced HIV medication error rates by more than 35%.

Most Popular

$vacMongoViewPlus$ $vAR$